6GF3 image
Entry Detail
PDB ID:
6GF3
Keywords:
Title:
Tubulin-Jerantinine B acetate complex
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
2018-04-29
Release Date:
2019-05-08
Method Details:
Experimental Method:
Resolution:
2.40 Å
R-Value Free:
0.25
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 21 21 21
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Tubulin alpha-1B chain
Chain IDs:A, C
Chain Length:451
Number of Molecules:2
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Description:Tubulin beta-2B chain
Chain IDs:B
Chain Length:445
Number of Molecules:1
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Description:Tubulin beta-2B chain
Chain IDs:D
Chain Length:445
Number of Molecules:1
Biological Source:Bos taurus
Polymer Type:polypeptide(L)
Description:Stathmin-4
Chain IDs:E
Chain Length:143
Number of Molecules:1
Biological Source:Rattus norvegicus
Polymer Type:polypeptide(L)
Description:Tubulin tyrosine ligase
Chain IDs:F
Chain Length:384
Number of Molecules:1
Biological Source:Gallus gallus
Primary Citation
Sustainable Syntheses of (-)-Jerantinines A & E and Structural Characterisation of the Jerantinine-Tubulin Complex at the Colchicine Binding Site.
Sci Rep 8 10617 10617 (2018)
PMID: 30006510 DOI: 10.1038/s41598-018-28880-2

Abstact

The jerantinine family of Aspidosperma indole alkaloids from Tabernaemontana corymbosa are potent microtubule-targeting agents with broad spectrum anticancer activity. The natural supply of these precious metabolites has been significantly disrupted due to the inclusion of T. corymbosa on the endangered list of threatened species by the International Union for Conservation of Nature. This report describes the asymmetric syntheses of (-)-jerantinines A and E from sustainably sourced (-)-tabersonine, using a straight-forward and robust biomimetic approach. Biological investigations of synthetic (-)-jerantinine A, along with molecular modelling and X-ray crystallography studies of the tubulin-(-)-jerantinine B acetate complex, advocate an anticancer mode of action of the jerantinines operating via microtubule disruption resulting from binding at the colchicine site. This work lays the foundation for accessing useful quantities of enantiomerically pure jerantinine alkaloids for future development.

Legend

Protein

Chemical

Disease

Primary Citation of related structures